US Biological Indicators Market Rapid-Readout Technologies
According to Rohan Patil, who specializes in sterility assurance solutions, biological validation systems, and microbial performance indicators, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the U.S. biological indicators market. The U.S. biological indicators market size was estimated at USD 185 million in 2025 and is predicted to increase from USD 426.06 million in 2026 to approximately USD 426.06 billion by 2035, expanding at a CAGR of 8.7% from 2026 to 2035. His analysis highlights the increasing adoption of sterilization demand, surgical procedures, infection control, and technological testing advancements. The research also examines the competitive strategies of key industry participants, including ASO (Fortive), Hu-Friedy, True Indicating, H.W. Anderson Products Ltd., and Propper Manufacturing Co., Inc., shaping the future by advancing sterility testing, pharmaceutical manufacturing, and expansion of healthcare facilities across the U.S. biological indicators market.
Last Updated : 23 June 2026
Category: Life Sciences
Insight Code: 6965
Format: PDF / PPT / Excel